Johnson & Johnson
JNJ
#22
Rank
NZ$940.76 B
Marketcap
NZ$390.81
Share price
0.97%
Change (1 day)
54.43%
Change (1 year)

Johnson & Johnson is a global American pharmaceutical and consumer goods company with headquarters in New Brunswick, New Jersey. The company is listed in the Dow Jones Industrial Average.

EPS for Johnson & Johnson (JNJ)

EPS in 2026 (TTM): NZ$14.91

According to Johnson & Johnson's latest financial reports the company's current EPS (TTM) is NZ$14.91. In 2025 the company made an earnings per share (EPS) of NZ$19.02 an increase over its 2024 EPS that were of NZ$11.42.

EPS history for Johnson & Johnson from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$14.91-21.6%
2025NZ$19.0266.46%
2024NZ$11.42-53.6%
2023NZ$24.62111.16%
2022NZ$11.66-13.84%
2021NZ$13.5341.81%
2020NZ$9.54-18.92%
2019NZ$11.7721.2%
2018NZ$9.711125.3%
2017NZ$0.79-92.23%
2016NZ$10.207.37%
2015NZ$9.50-4.16%
2014NZ$9.9118.1%
2013NZ$8.3924.88%
2012NZ$6.72

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
NZ$11.98-19.65%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.24-85.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$6.16-58.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
NZ$6.13-58.91%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
NZ$48.19 223.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$4.37-70.70%๐Ÿ‡ซ๐Ÿ‡ท France
Gilead Sciences
GILD
NZ$11.69-21.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Stryker Corporation
SYK
NZ$14.49-2.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$6.07-59.28%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$6.63-55.52%๐Ÿ‡ฌ๐Ÿ‡ง UK